Latest Breaking News On - Travere therapeutics bank - Page 1 : comparemela.com

The biotech stock with the BofA's biggest upside already has approval for a drug that treats a rare kidney disease affecting up to 150,000 people in the U.S.

United statesBio pharmaBridgebio bofa bioMary kate davisGreg harrisonRocket pharmaceuticals bofLiquidia corpTravere therapeutics bankRocket pharmaceuticalsWall streetBridgebio pharmaTravere therapeuticsTherapeutics bankTechnologies theLiquidia technologiesPharmaceuticals bofa